Wockhardt Limited
WOCKPHARMA
株式のランク
#4512
Wockhardt Limited, together with its subsidiaries, operates as a pharmaceutical... Wockhardt Limited, together with its subsidiaries, operates as a pharmaceutical and biotech company, in India, the United States, the United Kingdom, Switzerland, Ireland, Russia, Europe, and internationally. It manufactures and trades pharmaceuticals, medicinal chemical, and botanical products, as well as chemicals and chemical products. The company also develops its flagship antibiotic, ZAYNICH zidebactam/cefepime, a novel beta lactam enhancer mechanism for the treatment of sepsis and hospital/ventilator associated pneumonia; FOVISCU, an antibiotic for gram-negative infections; MIQNAF nafithromycin, which targets azithromycin-resistant community respiratory pathogens; and ODRATE, a once-daily combination of ertapenem and zidebactam for resistant gram-negative infections through outpatient parenteral antimicrobial therapy. In addition, it develops and commercializes insulin analogs, glucagon-like peptide-1 agonists, and novel combination drug products; Biovac-B, a recombinant hepatitis-B vaccine; Wepox, a recombinant human erythropoietin; Wosulin, a recombinant human insulin; and Glaritus, a recombinant insulin glargine. Further, the company offers delivery devices for insulin, including Dispopen disposable pen and Mypen reusable pen. Wockhardt Limited was founded in 1967 and is headquartered in Mumbai, India.
株価
$21.04
最終同期: 2026-10-19
時価総額
$3.42B
変化（1日）
-2.39%
変化（1年）
38.07%
国
IN
取引 Wockhardt Limited (WOCKPHARMA)
カテゴリー
Healthcare
Wockhardt Limited（WOCKPHARMA）の配当利回りの履歴
Wockhardt Limited（銘柄コード: WOCKPHARMA）の配当利回り（TTM）は2024-03-31時点で0.00%です。
過去5年間の平均配当利回り: 0.01%
過去5年間の平均配当利回り: 0.01%
Wockhardt Limited（WOCKPHARMA）の2004から2026までの配当利回りの履歴
各年末時点の配当利回り（TTM）
| 年 | 配当利回り | 変化 |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2025 | 0.00% | 0.00% |
| 2024 | 0.00% | 0.00% |
| 2023 | 0.00% | -100.00% |
| 2022 | 0.06% | 500.00% |
| 2021 | 0.01% | 0.00% |
| 2020 | 0.00% | 0.00% |
| 2019 | 0.00% | 0.00% |
| 2018 | 0.00% | -100.00% |
| 2017 | 1.60% | 0.00% |
| 2016 | 0.00% | -100.00% |
| 2015 | 1.10% | -63.46% |
| 2014 | 3.01% | 0.00% |
| 2013 | 0.00% | 0.00% |
| 2012 | 0.00% | 0.00% |
| 2011 | 0.00% | -100.00% |
| 2010 | 0.01% | -99.60% |
| 2008 | 2.49% | -28.86% |
| 2007 | 3.50% | 136.49% |
| 2006 | 1.48% | 26.50% |
| 2005 | 1.17% | 60.27% |
| 2004 | 0.73% | 0.00% |
類似企業または競合他社の配当利回り（TTM）
| 企業 | 配当利回り | 国 |
|---|---|---|
| 1.57% |
US
|
|
| 0.00% |
SE
|
|
| 0.00% |
FR
|
|
| 0.00% |
IT
|
|
| 0.00% |
US
|
